CHIP and epigenetic age acceleration can also be used to identify persons at high risk of all‐cause mortality and CHD, further reinforcing the importance of both phenotypes as valuable tools in precision medicine for aging. This evidence concerns the gene STUB1 and coronary artery disorder.